PWCM
Price
$0.49Alerts
Change
+$0.01 (+2.08%)
Updated
Nov 11 closing price
Capitalization
966.68K
2 days until earnings call
Intraday BUY SELL Signals
STEX
Price
$0.33Alerts
Change
-$0.01 (-2.94%)
Updated
Nov 11 closing price
Capitalization
39.48M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PWCM vs STEX

PWCM vs STEX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PWCM vs. STEX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PWCM is a Hold and STEX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for PWCM with price predictions
Nov 10, 2026

PWCM in upward trend: price may jump up because it broke its lower Bollinger Band on November 05, 2026

PWCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 34 cases where PWCM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PWCM's RSI Oscillator exited the oversold zone, 35 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 62 of 72 cases where PWCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

Following a +15.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where PWCM advanced for three days, in 190 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PWCM as a result. In 76 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PWCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PWCM entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.056) is normal, around the industry mean (3.120). P/E Ratio (-0.007) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (0.067) is also within normal values, averaging (16.899).

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. PWCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PWCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
a Summary for STEX with price predictions
Nov 10, 2026

STEX's Stochastic Oscillator remains in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STEX's RSI Indicator exited the oversold zone, 40 of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Moving Average Convergence Divergence (MACD) for STEX just turned positive on October 26, 2026. Looking at past instances where STEX's MACD turned positive, the stock continued to rise in 38 of 45 cases over the following month. The odds of a continued upward trend are 84%.

Following a +12.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where STEX advanced for three days, in 217 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STEX as a result. In 75 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for STEX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. STEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.271) is normal, around the industry mean (3.120). P/E Ratio (-0.038) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. STEX's P/S Ratio (526.316) is very high in comparison to the industry average of (16.899).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

FUNDAMENTALS RATINGS
PWCM vs STEX: Fundamental Ratings
PWCM
STEX
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9591
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PWCM's Valuation (59) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for STEX (99) in the Medical Specialties industry. This means that PWCM’s stock grew somewhat faster than STEX’s over the last 12 months.

PWCM's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as STEX (100) in the Medical Specialties industry. This means that PWCM’s stock grew similarly to STEX’s over the last 12 months.

PWCM's SMR Rating (99) in the Miscellaneous Commercial Services industry is in the same range as STEX (100) in the Medical Specialties industry. This means that PWCM’s stock grew similarly to STEX’s over the last 12 months.

STEX's Price Growth Rating (91) in the Medical Specialties industry is in the same range as PWCM (95) in the Miscellaneous Commercial Services industry. This means that STEX’s stock grew similarly to PWCM’s over the last 12 months.

PWCM's P/E Growth Rating (6) in the Miscellaneous Commercial Services industry is in the same range as STEX (9) in the Medical Specialties industry. This means that PWCM’s stock grew similarly to STEX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PWCMSTEX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (PWCM: $0.48 vs. STEX: $0.34)
Brand notoriety: PWCM and STEX are both not notable
Both companies represent the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: PWCM: 34% vs. STEX: 34%
Market capitalization -- PWCM: $966.68K vs. STEX: $39.48M
PWCM [@Investment Banks/Brokers] is valued at $966.68K. STEX’s [@Investment Banks/Brokers] market capitalization is $39.48M. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $284.96B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PWCM’s FA Score shows that 1 FA rating(s) are green while STEX’s FA Score has 1 green FA rating(s).

  • PWCM’s FA Score: 1 green, 4 red.
  • STEX’s FA Score: 1 green, 4 red.
According to our system of comparison, PWCM is a better buy in the long-term than STEX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PWCM’s TA Score shows that 4 TA indicator(s) are bullish while STEX’s TA Score has 4 bullish TA indicator(s).

  • PWCM’s TA Score: 4 bullish, 3 bearish.
  • STEX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both PWCM and STEX are a good buy in the short-term.

Price Growth

PWCM (@Investment Banks/Brokers) experienced а -16.40% price change this week, while STEX (@Investment Banks/Brokers) price change was -11.58% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -3.40%. For the same industry, the average monthly price growth was -18.39%, and the average quarterly price growth was -23.03%.

Reported Earning Dates

PWCM is expected to report earnings on Nov 13, 2026.

STEX is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Investment Banks/Brokers (-3.40% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

View a ticker or compare two or three
Interact to see
Advertisement

PWCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PWCM has been loosely correlated with BMNR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PWCM jumps, then BMNR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PWCM
1D Price
Change %
PWCM100%
-12.32%
BMNR - PWCM
38%
Loosely correlated
-2.85%
BTCS - PWCM
37%
Loosely correlated
-2.65%
KEEL - PWCM
37%
Loosely correlated
-2.55%
GLXY - PWCM
36%
Loosely correlated
-2.76%
DEFT - PWCM
33%
Loosely correlated
-7.97%
More

STEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, STEX has been loosely correlated with KEEL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STEX jumps, then KEEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEX
1D Price
Change %
STEX100%
-8.60%
KEEL - STEX
35%
Loosely correlated
-2.55%
BTBT - STEX
34%
Loosely correlated
-7.38%
PWCM - STEX
32%
Poorly correlated
-12.32%
BMNR - STEX
31%
Poorly correlated
-2.85%
CLSK - STEX
30%
Poorly correlated
-4.92%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD4.270.13
+3.14%
Relmada Therapeutics
CING4.560.11
+2.47%
Cingulate Inc
SPB88.69-0.64
-0.72%
Spectrum Brands Holdings
FRO43.87-0.42
-0.95%
Frontline Plc
ONFO0.36-0.01
-3.95%
Onfolio Holdings Inc